141 related articles for article (PubMed ID: 16225480)
41. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
[TBL] [Abstract][Full Text] [Related]
42. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
43. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
44. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
[TBL] [Abstract][Full Text] [Related]
45. [Steatosis in chronic viral hepatitis C: frequency, risk factors and relationship with fibrosis].
Karoui S; Taieb Jomni M; Bellil K; Haouet S; Boubaker J; Filali A
Tunis Med; 2008 Jul; 86(7):670-5. PubMed ID: 19472729
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus core protein, lipid droplets and steatosis.
Roingeard P; Hourioux C
J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
[TBL] [Abstract][Full Text] [Related]
47. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
[TBL] [Abstract][Full Text] [Related]
48. [Pathomechanism of metabolic disorders in HCV infection].
Boroń-Kaczmarska A
Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
[TBL] [Abstract][Full Text] [Related]
49. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
[TBL] [Abstract][Full Text] [Related]
50. No increase in the expression of key unfolded protein response genes in HCV genotype 3 patients with severe steatosis.
Congiu M; Ryan MC; Desmond PV
Virus Res; 2011 Sep; 160(1-2):420-3. PubMed ID: 21741418
[TBL] [Abstract][Full Text] [Related]
51. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
[TBL] [Abstract][Full Text] [Related]
52. Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype.
Oliveira AC; Parise ER; Catarino RM; Lanzoni V; Leite-Mor MM; Simon KA; Junqueira VB
Free Radic Res; 2009 Dec; 43(12):1187-94. PubMed ID: 19905981
[TBL] [Abstract][Full Text] [Related]
53. Steatosis correlates with hepatic expression of death receptors and activation of nuclear factor-kappaB in chronic hepatitis C.
Hung CH; Lee CM; Kuo FY; Jiang SR; Hu TH; Chen CH; Wang JH; Lu SN; Eng HL; Changchien CS
Liver Int; 2008 Mar; 28(3):339-46. PubMed ID: 18290776
[TBL] [Abstract][Full Text] [Related]
54. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
[TBL] [Abstract][Full Text] [Related]
55. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India.
Chakravarti A; Verma V
Transfus Med; 2006 Dec; 16(6):433-8. PubMed ID: 17163874
[TBL] [Abstract][Full Text] [Related]
56. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
57. [ANRS HC 02 RIBAVIC: impact of steatosis in HIV-HCV co-infection].
Pol S
Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S110-2. PubMed ID: 19375038
[TBL] [Abstract][Full Text] [Related]
58. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas and HLA antigens.
Caronia S; McGarvey MJ; Goldin RD; Foster GR
J Viral Hepat; 2004 Nov; 11(6):511-8. PubMed ID: 15500551
[TBL] [Abstract][Full Text] [Related]
59. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
60. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
